Life sciences

Tile for Not quite Reddy – lessons on strategy for generic launches in the life sciences sector
November 11, 2025

Not quite Reddy – lessons on strategy for generic lau...

The recent High Court decision in Dr Reddy's Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH [2025] EWHC 2834 (Pat)...
Read more
Tile for Healthcare financing and reimbursement in the UK – Stevens & Bolton’s recent contribution to the International Bar Association
July 7, 2025

Healthcare financing and reimbursement in the UK – St...

We were delighted to participate in the International Bar Association (IBA) Healthcare and Life Sciences Law Committee 2025 survey on...
Read more
Tile for Continued acceleration in the use and regulation of AI in the UK life sciences industry
June 26, 2025

Continued acceleration in the use and regulation of AI ...

The expanding role of AI in life sciences AI-driven models are increasingly used by pharmaceutical and biotechnology companies to...
Read more
Tile for Counterfeit pharmaceuticals: innovative strategies for combatting global health threats in the UK
June 25, 2025

Counterfeit pharmaceuticals: innovative strategies for ...

The pharmaceutical industry is one of the UK’s leading industrial sectors, contributing around £15bn in gross value added (GVA) to the...
Read more